Search clinical trials for: Effcacy
Total 1 results
-
Biotech Pharmaceutical Co., Ltd.Unknown
Sponsors and Collaborators
- Carlos III Health Institute
- Epicentre, Paris, France.
- Health Holding Company, Hail Health Cluster, Saudi Arabia
- Australian Childhood Foundation
- Prader-Willi Syndrome Association of Australia
- The Depressive and Bipolar Disorder Alternative Treatment Foundation
- Sociedad Española de Arteriosclerosis
- Sonogenix
- Kettering Foundation
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- Laboratoires Iprad-Vegebom
- Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
- Remedy Institute
- wenbinlu
- Zhijun Sun
- NATURAmedicatrix Sàrl
- Resurge Therapeutics Inc.
- Paul W. Read, MD
- Brigham and Womens' Hospital, Center for Surgery and Public Health
- Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
- View Full List
Medical Conditions
- High Caries Risk Patients
- IgG Monoclonal Gammopathy of Uncertain Significance
- Coughing Responses at Tracheal Extubation
- Excessive Ear Wax
- Insulin Injection Pad
- Sacral Dysgenesis
- Coronary Heart Diseases
- Tooth Restoration
- Spastic Paraplegia Type 5A, Recessive
- Pars Planitis
- Lip Rejuvenation
- Effectiveness of MedCem MTA® in Pulpotomies Primary Teeth
- SIN3A
- Whipples Procedure
- Dystonia 19
- Emergence Agitation
- Perimyocarditis
- Orthopaedic Disorders
- Idiopathic Chronic Inflammatory Bowel Disease
- Body Odor
- View Full List
Drug Interventions
- Colecalciferol D3 (Vigantol Oil)
- Fostamatinib
- FRSW107
- Everolimus
- Low molecular weight Heparin as standard of care treatment
- Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
- Oral Aztreonam
- Fenofibric acid 135mg
- Irinotecan
- Triple therapy
- Epalrestat
- Omeprazole 40 mg
- Optiva artificial tear by Allergan
- Gadoteridol (ProHance)
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- Lansoprazole 15mg QD
- SBI-087
- LINjeta U-100 Insulin
- ART-123
- 300 mg of caffeine citrate infusion
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Congo
- Contract Research Organizations in France
- Contract Research Organizations in Ireland
- Contract Research Organizations in Israel
- Contract Research Organizations in Italy
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Norway
- Contract Research Organizations in Philippines
- Contract Research Organizations in Qatar
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Turkmenistan
- CRO list by country